Sales will be suspended “until January 31, 2023”.
The government banned the online sale of paracetamol products until the end of January on Wednesday, in a context of persistent difficulties in supplying this ubiquitous drug in medicine cabinets. “The online sale of specialties composed exclusively of paracetamol is suspended until January 31, 2023“, decreed the government in a decree published in the Official Journal. This decision takes note of the fact thattensions in paracetamol-based drugs have continued for more than six monthsespecially for forms intended for children.
“The various measures taken by the health authorities, however effective they may have been, have so far failed to put an end to it.“, acknowledges the decree. For several months, the National Medicines Safety Agency (ANSM) has been asking pharmacists to ration the sale of paracetamol to each patient, an emblematic painkiller which is used in particular as a basis for Sanofi’s Doliprane and Dafalgan. In December, the Ministry of Health had already warned that, despite these measures, the situation remained “complexand would not resolve for several weeks. The government, in its decree, highlights in particular the worsening health situation in China, where Covid cases are exploding after a sudden lifting of drastic health restrictions.
Read alsoMedicines: amoxicillin and paracetamol still available, assures the government
The Chinese government has banned the export of paracetamol, while the country produces a large part of the active ingredient used by laboratories around the world. These supply difficulties are also part of a broader context of shortages of multiple drugs, in France or other countries, starting with antibiotics such as amoxicillin.